第VIII因子欠乏症治療の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Factor VIII Deficiency Treatment Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Highlights

PART 05: Deficiency overview

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by type of disease application
• Global hemophilia A drugs market
• Global hemophilia A inhibitors treatment market
• Global von Willebrand disease treatment market

PART 09: Market segmentation by type of therapy
• Recombinant therapies
• Plasma-derived therapies

PART 10: Market segmentation by type of disease management
• Prophylaxis
• On-demand therapy
• Inhibitor therapy

PART 11: Geographical segmentation
• Factor VIII deficiency treatment market in Americas
• Factor VIII deficiency treatment market in EMEA
• Factor VIII deficiency treatment market in APAC

PART 12: Market drivers
• Increasing adoption of prophylactic drugs
• Paradigm shift toward the development of drugs with extended half-life
• Large patient pool driving the shipments of factor VIII units

PART 13: Impact of drivers

PART 14: Market challenges
• Low diagnosis rate affecting the market growth
• High entry barriers
• Cost-intensive complex treatment

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Increase in technological innovations
• Development of gene therapy products
• Expansion initiatives of vendors fueling the market growth
• Increasing investments of vendors to improve the production capability

PART 17: Vendor landscape
• Competitive scenario

PART 18: Key vendor analysis
• Bayer HealthCare
• CSL
• Grifols
• Novo Nordisk
• Pfizer
• Shire
• Other prominent vendors

PART 19: Appendix
• List of abbreviation

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Process of gene therapy
Exhibit 03: Key buying criteria for global factor VIII deficiency treatment market 2016 and 2021
Exhibit 04: Key customer segments of factor VIII deficiency treatment market
Exhibit 05: Pipeline analysis as of 2016
Exhibit 06: Key clinical trials
Exhibit 07: Global factor VIII deficiency treatment market snapshot
Exhibit 08: Global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 09: Global factor VIII deficiency treatment market by volume 2016-2021 (million units)
Exhibit 10: Impact of factors affecting the market 2016 and 2021
Exhibit 11: Opportunity analysis in global factor VIII deficiency treatment market
Exhibit 12: Five forces analysis
Exhibit 13: Global factor VIII therapy in hemophilia A market 2016-2021 ($ millions)
Exhibit 14: Global factor VIII therapy in hemophilia A inhibitors market 2016-2021 ($ millions)
Exhibit 15: Global factor VIII therapy in von Willebrand disease treatment market 2016-2021 ($ millions)
Exhibit 16: Recombinant therapies in global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 17: Plasma-derived therapies in global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 18: Segmentation of factor VIII drugs market by type of disease management based on revenue 2016
Exhibit 19: Segmentation of global factor VIII deficiency treatment market based on geography 2016 and 2021
Exhibit 20: Factor VIII deficiency treatment market revenue by geography 2016-2021 (%)
Exhibit 21: Market scenario in Americas
Exhibit 22: Factor VIII deficiency treatment market in Americas 2016-2021 ($ billions)
Exhibit 23: Market scenario in EMEA
Exhibit 24: Factor VIII deficiency treatment market in EMEA 2016-2021 ($ billions)
Exhibit 25: Market scenario in APAC
Exhibit 26: Factor VIII deficiency treatment market in APAC 2016-2021 ($ billions)
Exhibit 27: Incidence rates of factor VIII deficiency
Exhibit 28: YoY shipments of factor VIII units 2012-2016 (million units)
Exhibit 29: Impact of drivers
Exhibit 30: Diagnosis and treatment trends of hemophilia A 2013
Exhibit 31: Percentage share of diagnosed and undiagnosed hemophilia population 2012-2016
Exhibit 32: Forcefield analysis of drivers and challenges
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Competitive structure analysis of global factor VIII deficiency treatment market 2016
Exhibit 35: Competitive analysis of global factor VIII deficiency treatment market
Exhibit 36: Market share analysis 2016
Exhibit 37: Market penetration of various factor VIII manufacturers worldwide 2016
Exhibit 38: Strategic success factors of companies in global factor VIII deficiency treatment market
Exhibit 39: Key highlights
Exhibit 40: Bayer HealthCare: Strength assessment
Exhibit 41: Bayer HealthCare: Strategy assessment
Exhibit 42: Bayer HealthCare: Opportunity assessment
Exhibit 43: Bayer HealthCare: YoY revenue and growth rate of Kogenate 2013-2015 ($ billions)
Exhibit 44: Key highlights
Exhibit 45: CSL: Strength assessment
Exhibit 46: CSL: Strategy assessment
Exhibit 47: CSL: Opportunity assessment
Exhibit 48: Key highlights
Exhibit 49: Grifols: Strength assessment
Exhibit 50: Grifols: Strategy assessment
Exhibit 51: Grifols: Opportunity assessment
Exhibit 52: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
Exhibit 53: Key highlights
Exhibit 54: Novo Nordisk: Strength assessment
Exhibit 55: Novo Nordisk: Strategy assessment
Exhibit 56: Novo Nordisk: Opportunity assessment
Exhibit 57: Novo Nordisk: YoY revenue and growth of hemophilia segment 2013-2015
Exhibit 58: Key highlights
Exhibit 59: Pfizer: Strength assessment
Exhibit 60: Pfizer: Strategy assessment
Exhibit 61: Pfizer: Opportunity assessment
Exhibit 62: Pfizer: YoY revenue and growth rate of Xyntha/ReFacto AF 2013-2015 ($ millions)
Exhibit 63: Key highlights
Exhibit 64: Shire: Strength assessment
Exhibit 65: Shire: Strategy assessment
Exhibit 66: Shire: Opportunity assessment
Exhibit 67: Baxalta: YoY revenue comparison of hemophilia segment 2013-2015 ($ billions)
Exhibit 68: Baxalta: Geographic segmentation of hemophilia by revenue 2015


【レポート販売概要】

■ タイトル:第VIII因子欠乏症治療の世界市場2017-2021
■ 英文:Global Factor VIII Deficiency Treatment Market 2017-2021
■ 発行日:2017年3月6日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12140
■ 調査対象地域:グローバル
  • 非小細胞肺癌:世界の臨床試験レビュー(2014年上半期)
    Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Small Cell Lung Cancer. It includes an overview of the t …
  • セラミックマトリックス複合材(CMC)の世界市場分析:製品別(酸化物、炭化ケイ素(SiC)、炭素)、用途別(航空宇宙、防衛、エネルギー・電力、電気・電子)、セグメント予測
    The global ceramic matrix composites (CMC) market is expected to reach USD 6.0 billion by 2024, according to a new report by Grand View Research, Inc. High thermal stability and electrical conductivity have made ceramic matrix composites desirable in various thermal management applications where high efficiency and weight to strength ratio is required. CMCs observe strong demand from aerospace, de …
  • Daleco Resources Corporation:石油・ガスの開発・生産動向及びコスト分析- 2012
    Daleco Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Daleco Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
  • 世界のポータブル空調装置市場:Global Portable Air Conditioning System Market 2014-2018
    TechNavio's analysts forecast the Global Portable Air Conditioning System market to grow at a CAGR of 12.56 percent over the period 2013-2018. One of the key factors contributing to this market growth is the high demand from North America and Europe. The Global Portable Air Conditioning System market has also been witnessing the increasing adoption of inverter-based portable air conditioners. Howe …
  • 世界の緊急管理及び突発事象管理市場
    Emergency Management and Incident Management refers to the process of planning, preparing, responding, recovering, and mitigating any incident and emergency which would occur due to natural or man-made disasters. Incident and emergency management plays an important role in securing the society as well as the infrastructure as a whole. The management refers to the usage of specific systems and solu …
  • オートサンプラーの世界市場予測(~2022年)
    The global autosamplers market is projected to reach USD 1.14 Billion by 2022 from USD 0.79 Billion in 2017, at a CAGR of 7.6% during the forecast period. Advantages of autosamplers over manual injection systems, growing importance of chromatography in drug approvals, and increasing production of crude and shale oil are some of the key factors driving the growth of the market. This report broadly …
  • 商用テレマティクスの世界市場2016-2020
    About Commercial Telematics Telematics is an automated system designed for vehicles that incorporates communication systems for real-time information transfer to achieve efficient solutions. Auto manufacturers have many options for online connectivity in vehicles to deliver two-way communication. These options include embedded telematics, tethered telematics, and integrated smartphone telematics. …
  • 世界のガリウム砒素(GaAs)デバイス市場2015
    The Global Gallium arsenide (GaAs) Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Gallium arsenide (GaAs) Devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Gallium arsenide (GaAs) Devices market analysis is provided for the intern …
  • 民間航空機用フライトコントロールシステム(FCS)の世界市場
    About the Commercial Aircraft Flight Control Systems (FCS) Market Flight control systems (FCS) consist of primary and secondary systems. Ailerons, elevators, and rudder constitute the primary FCS and are required to control an aircraft for safe flight. On the other hand, wing flaps, spoilers, leading edge devices, and trim systems constitute the secondary FCS. Secondary FCS enhance the performance …
  • ソーシャル+LTE+コマースの市場機会分析:Market Opportunity: Social + LTE + Commerce
    Mobile commerce is transforming from more than just banking, coupons, and checkout to become a more transcendent medium for all aspects of commerce. It is important to recognize that commerce is more than purchasing. Commerce starts with an impression, leading to a purchase decision, and ultimately a purchase. There is a lot of money in the entire value chain, especially considering the huge amoun …
  • 個人用緊急対応システム(PERS)の世界市場2016-2020
    About Personal Emergency Response System The rapid growth of the global population raises concerns about the well-being of the older people as they may become vulnerable due to diminished communication capabilities, health challenges, financial circumstances, and chronic or terminal illness. PERS for hospital and at-home care is a critical device, which is designed to signal the presence of a haza …
  • 酒さ(Rosacea):世界の治験レビュー(2015年上半期版)
    Rosacea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, H1, 2015" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Th …
  • JSC Exploration and Production KazMunaiGas:石油・ガスバリューチェーン分析レポート2013
    JSC Exploration and Production KazMunaiGas Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "JSC Exploration and Production KazMunaiGas" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “JSC Exploration and Production KazMunaiGas”. The report provides key information relating to oil and gas assets of the company …
  • 2014年戦略提言:ドイツの呼吸器病診断検査市場
    About This ReportThis new 283-page report from Venture Planning Group presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addi …
  • 欧州の弓用具市場2016-2020
    About Archery Equipment in Europe The archery equipment market in Europe is driven by many growth factors — the positive influence of the ATA trade shows being one of the most important. The growing influence of media, especially movies and television broadcasting of archery games in the Olympics, is aiding in the market's growth in the region. The budding interest exhibited by the European popula …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。